An observational study on the prevalence of congenital hypothyroidism and factors affecting TSH levels in premature babies at tertiary care rural centre
DOI:
https://doi.org/10.18203/2349-3291.ijcp20232251Keywords:
Congenital hypothyroidism, Preterm babies, Risk factors, TSH levels, PrevalenceAbstract
Background: Premature babies, particularly those with very low birth weight (VLBW), are at a higher risk of developing congenital hypothyroidism. The inadequate development of the hypothalamic-pituitary axis in preterm infants contributes to the higher prevalence of this condition in this population. However, the optimal screening and treatment protocols for congenital hypothyroidism in preterm newborns remain unclear.
Methods: This was a hospital-based observational study conducted over a period of 18 months. The study included 150 preterm babies born at the Sri Adichunchanagiri hospital and research centre. Non-probability sampling was used to select the study subjects. Data on demographic and clinical factors were collected from mothers and newborns. Blood samples were collected at day 3 of life to estimate thyroid-stimulating hormone levels. Correlations between TSH levels and various parameters were analyzed using statistical methods.
Results: The study found that the prevalence of congenital hypothyroidism in preterm newborns was 2%. The mean TSH level at day 3 was 7.56 mIU/L, and 9.3% of cases had TSH levels above 20 mIU/l. Significant associations were found between high TSH levels and primiparity, vaginal delivery, and maternal gestational diabetes mellitus. There was an inverse correlation between TSH levels and gestational age, birth weight, and Apgar scores at 1 and 5 minutes.
Conclusions: The study revealed a prevalence of congenital hypothyroidism of 2% in preterm newborns. Risk factors such as primiparity, vaginal delivery, and maternal GDM were associated with high TSH levels. These findings highlight the importance of screening and early detection of congenital hypothyroidism in premature babies to improve outcomes.
Metrics
References
Sanghvi U, Diwakar KK. Universal screening for congenital hypothyroidism. Indian Pediatr. 2008;45: 331-2.
Ford G, LaFranchi SH. Screening for congenital hypothyroidism: a worldwide view of strategies. Best Pract Res Clin Endocrinol Metab. 2014;28(2):175-87.
Dussault JH, Coulombe P, Laberge C, Letarte J, Guyda H, Khoury K. Preliminary report on a mass screening program for neonatal hypothyroidism. J Pediatr. 1975; 86:670-4.
Mitchell ML, Hsu HW. Massachusetts Pediatric Endocrine Work Group. Unresolved issues in the wake of newborn screening for congenital hypothyroidism. J Pediatr 2016;173:228-31.
Wu LL, Sazali BS, Adeeb N, Khalid BAK. Congenital hypothyroid screening using cord blood TSH. Singapore Med J. 1999;40:23-6.
Ordookhani A, Mirmiran P, Najafi R, Hedayati M, Azizi F. Congenital hypothyroidism in Iran. Indian J Pediatr. 2003;70:625-8.
Murphy N, Hume R, van Toor H, Matthews TG, Ogston SA, Wu SY, et al. The hypothalamic–pituitary–thyroid axis in preterm infants; changes in the first 24 hours of postnatal life. J Clin Endocrinol Metab. 2004; 89:2824-31.
Hunter MK, Mandel SH, Sesser DE, Miyabira RS, Rien L, Skeels MR, et al. Follow-up of newborns with low thyroxine and non-elevated thyroid-stimulating hormone-screening concentrations: results of the 20-year experience in the Northwest regional newborn screening program. J Pediatr. 1998;132:70-4.
Woo HC, Lizarda A, Tucker R, Mitchell ML, Vohr B, Oh W, et al. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr, 2011;158:538-42.
Dinushan A. Low thyroxine and non-elevated thyroid-stimulating hormone-screening concentration. Journal Pediatr. 2019;04:1-5.
Giulia Di Dalmazi, et al. A detailed analysis of the factors influencing neonatal TSH: Results from a 6-year Congenital Hypothyroidism Screening Programme. Front Endocrinol. 2020.
Maria Cristina Vigone, MD. Yhyroid-stimulating hormone. J Pediatr. 2014;164:6.
Anne RP, Rahiman EA. Congenital hypothyroidism in India: A systematic review and meta-analysis of prevalence, screen positivity rates, and etiology. Lancet Regional Health-Southeast Asia. 2022;23: 100040.
Chung HR, Shin CH, Yang SW, Choi CW, Kim BI, Kim EK, et al. High incidence of thyroid dysfunction in preterm infants. J Korean Med Sci. 2009;24(4):627-31.
Kaluarachchi DC, Colaizy TT, Pesce LM, Tansey M, Klein JM. Congenital hypothyroidism with delayed thyroid-stimulating hormone elevation in premature infants born at less than 30 weeks gestation. J Perinatol. 2017;37(3):277-82.
Lee JH, Kim SW, Jeon GW, Sin JB. Thyroid dysfunction in very low birth weight preterm infants. Korean J Pediatr. 2015;58(6):2249.
Murphy N, Hume R, van Toor H, Matthews TG, Ogston SA, Wu SY, et al. The hypothalamic-pituitary-thyroid axis in preterm infants; changes in the first 24 hours of postnatal life. J Clin Endocrinol Metab. 2004; 89(6):2824-31.
Gupta A, Srivastava S, Bhatnagar A. Cord blood thyroid stimulating hormone level interpretation in light of perinatal factors. Indian Pediatr. 2014;51(1): 32-6.
Manglik AK, Chatterjee N, Ghosh G. Umbilical cord blood TSH levels in term neonates: a screening tool for congenital hypoth: 1029-32.
Mekonnen Y, Gizachew WH, Chamiso B, Raue F. Thyroid stimulating hormone values in cord blood in neonates. Ethiop J Health Dev. 2003;17:125-30.
Klein AH, Agustin AV, Foley TP. Successful laboratory screening for congenital hypothyroidism. Lancet. 1974;2:77-9.
Downloads
Published
How to Cite
Issue
Section
